There are studies in mice where selective deletion of JAK2 in hepatocytes was shown to protect against steatosis and glucose intolerance induced by the intake of a high-fat diet [28], whereas patients with portal vein thrombosis associated with a point mutation in the JAK2 gene had a higher proportion of hepatocarcinoma [29]. The gene discussed is JAK2; the disease is steatosis.